Literature DB >> 28717084

Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis.

Hideaki Yamakawa1,2, Akimasa Sekine1, Yumie Yamanaka1,2, Shinko Sadoyama1, Tomohisa Baba1, Eri Hagiwara1, Koji Okudela3, Takashi Ogura1.   

Abstract

Some forms of idiopathic retroperitoneal fibrosis (RF) have recently been considered to be a part of the spectrum of immunoglobulin G4 (IgG4)-related disease. This case report is the first description of a spontaneous remission in a patient with pathologically proven IgG4-related RF. Although the pathogenesis and long-term disease behavior of IgG4-related RF remains unknown, we believe that an initial assessment consisting of only careful monitoring might be one important strategy, especially in asymptomatic IgG4-related RF patients without nephropathy, while carefully monitoring these patients for the risk of recurrence.

Entities:  

Keywords:  IgG4-related disease; retroperitoneal fibrosis; spontaneous remission

Mesh:

Substances:

Year:  2017        PMID: 28717084      PMCID: PMC5548681          DOI: 10.2169/internalmedicine.56.7996

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Retroperitoneal fibrosis (RF) is a rare disease characterized by the development of inflammation and fibrosis in the soft tissues of the retroperitoneum and other abdominal organs (1). The radiologic findings of a soft-tissue mass surrounding the abdominal aorta and the iliac arteries, with the possible encasement of neighboring structures, such as the ureters and the inferior vena cava, usually suggests a diagnosis of RF (2). Recent reports have shown that to some extent, that cases of idiopathic RF included immunoglobulin G4 (IgG4)-related RF (3). However, the concept of IgG4-related disease is relatively new, and few studies have so far been published on this disease. Patients with RF and associated with clinical symptoms (e.g., fatigue, weight loss, abdominal or back pain) or those with hydronephrosis and acute renal failure caused by ureteral obstruction usually require steroid therapy, regardless of the cause of RF (4). Therefore, the natural course of this disease remains unknown. We herein report a pathologically proven case of a spontaneous remission of IgG4-related RF.

Case Report

A 72-year-old man who was an ex-smoker (3 packs/day for 42 years) had no known history of dust exposure including asbestos. He had a medical history of cerebral infarction 10 years perviously and chronic kidney disease (CKD) [estimated glomerular filtration rate (eGFR) of 46.8-57.1 mL/min/1.73 m2 for the past 2 years]. He initially presented with complaints of fever, cough, and right-sided chest pain for one week and was then referred to our hospital. The physical examination on admission did not reveal any eruptions or swelling of joints, superficial lymph nodes, lacrimal glands, or salivary glands. His body temperature was elevated at 38.6℃. An enhanced computed tomography (CT) scan revealed slight bilateral pleural effusion, a soft tissue mass surrounding the abdominal aorta, and bilateral hydronephrosis caused by sequential thickening of the retroperitoneum with encasement of both ureters, which were suspected to indicate RF (Fig. 1A-C). No other abnormalities, such as lymphadenopathy or abnormal kidney findings (e.g., multiple low-density areas, hypovascular solitary mass, hypertrophic renal pelvic wall) were revealed. The laboratory findings were as follows: leukocyte count 11,000 /μL (74.7% neutrophils, 12.5% lymphocytes, 9.5% monocytes, and 3.1% eosinophils), hemoglobin 13.1 g/dL, thrombocytes 37.5×104/μL, creatinine 1.01 mg/dL (eGFR of 56.2 mL/min/1.73 m2), total bilirubin 0.4 mg/dL, and elevated levels of aspartate aminotransferase of 62 IU/L, alanine aminotransferase of 61 IU/L, gamma-glutamyl transpeptidase of 91 IU/L, alkaline phosphatase of 404 IU/L, lactate dehydrogenase of 255 IU/L, C-reactive protein (CRP) of 18.16 mg/dL, erythrocyte sedimentation rate of 114 mm/h, immunoglobulin G (IgG) of 2,515 mg/dL, IgG4 of 185 mg/dL, and soluble interleukin (IL)-2 receptor of 1,490 U/mL. IL-6 was not elevated at <8 pg/mL. Anti-nuclear antibody was less than 40 titers according to immunofluorescence testing, and no other autoantibodies including anti-SS-A, anti-aminoacyl tRNA synthetase antibody, rheumatoid factor, or anti-cyclic citrullinated peptide antibody were detected.
Figure 1.

Computed tomography (CT) performed at initial presentation (A-C) and 2 months after the diagnosis of IgG4-related retroperitoneal fibrosis (RF) (D-F). (A-C): CT on admission showed bilateral pleural effusion, a soft tissue mass surrounding the abdominal aorta, and bilateral hydronephrosis caused by sequential thickening of the retroperitoneum with encasement of both ureters. (D-F): Two months after the diagnosis of IgG4-related RF, CT showed improvement of the retroperitoneal lesions.

Computed tomography (CT) performed at initial presentation (A-C) and 2 months after the diagnosis of IgG4-related retroperitoneal fibrosis (RF) (D-F). (A-C): CT on admission showed bilateral pleural effusion, a soft tissue mass surrounding the abdominal aorta, and bilateral hydronephrosis caused by sequential thickening of the retroperitoneum with encasement of both ureters. (D-F): Two months after the diagnosis of IgG4-related RF, CT showed improvement of the retroperitoneal lesions. We initially started antibiotic therapy with ceftriaxone (2.0 g/day) because of the possibility of bacterial pleurisy as indicated by the clinical symptoms and existence of the pleural effusion. At the same time, because we suspected RF based on his radiological findings, we discontinued the aspirin he was taking to prevent a recurrence of cerebral infarction and began heparin bridging therapy before performing a biopsy on this patient to obtain a definitive diagnosis. After 1 week, the patient's condition improved slightly, his CRP level decreased to 10.15 mg/dL, and antibiotic therapy was thus stopped. We then performed a CT-guided biopsy of the mass lesion surrounding the abdominal aorta (Fig. 2). The biopsy samples from the retroperitoneal mass showed lymphoplasmacytic infiltration and fibrosis, and the infiltration of IgG4+ plasma cells with a ratio of IgG4+/IgG+cells>50%. Storiform fibrosis was also present (Fig. 3). Therefore, we diagnosed the patient to have IgG4-related RF. During this hospitalization for the biopsy, his initial symptoms (including fever, cough, and right-sided chest pain) improved, and his serum CRP level decreased to 2.51 mg/dL on the 14th hospital day. In addition, as there was no apparent worsening of his kidney disease, he was therefore discharged from the hospital. Immediately after discharge, he underwent an 18F-fluorodeoxyglucose (FDG)-positron emission tomograph (PET)/CT scan, which showed a mild FDG uptake [standardized uptake value (SUV)max 3.5] within the retroperitoneal mass, but no other suspicious findings of IgG4-related disease. Therefore, we considered the possibility of this patient having both IgG4-related pleurisy as the cause of his pleural effusion and IgG4-related kidney disease as the cause of his CKD to be low, and thus we diagnosed RF as a single IgG4-related lesion.
Figure 2.

Computed tomography (CT)-guided percutaneous needle biopsy for muddiness of the retroperitoneal mass lesion (dotted circle). (A) Marking of the biopsy entry site on the CT image in the prone position. (B) CT guided percutaneous fine needle aspiration biopsies using 18G cutting needles.

Figure 3.

Histopathological findings of the retroperitoneal mass lesion. Lymphoplasmacytic infiltration and fibrosis were seen (A) [Hematoxylin and Eosin (H&E) staining, ×200]. Storiform fibrosis was also present (B) (H&E staining, ×400). IgG immunohistochemical staining revealed that most of the infiltrating plasma cells were positive (×400). IgG4 immunohistochemical staining revealed that more than 50% of the IgG-positive plasma cells were positive for IgG4 (×400).

At 2 months following the diagnosis of IgG4-related RF, he had no complaints, and his CRP level had decreased to within the normal range, and his IgG4 had also decreased to 41 mg/dL. Moreover, radiological findings showed an improvement of the retroperitoneal lesions (Fig. 1D-F). He recently underwent a follow-up outpatient examination that showed no relapse of RF for 10 months. Computed tomography (CT)-guided percutaneous needle biopsy for muddiness of the retroperitoneal mass lesion (dotted circle). (A) Marking of the biopsy entry site on the CT image in the prone position. (B) CT guided percutaneous fine needle aspiration biopsies using 18G cutting needles. Histopathological findings of the retroperitoneal mass lesion. Lymphoplasmacytic infiltration and fibrosis were seen (A) [Hematoxylin and Eosin (H&E) staining, ×200]. Storiform fibrosis was also present (B) (H&E staining, ×400). IgG immunohistochemical staining revealed that most of the infiltrating plasma cells were positive (×400). IgG4 immunohistochemical staining revealed that more than 50% of the IgG-positive plasma cells were positive for IgG4 (×400).

Discussion

RF is a rare syndrome hallmarked by fibrosclerotic tissue in the retroperitoneum, often leading to encasement of the ureters (5). RF is generally divided into two types: idiopathic RF, for which no clear cause is known, and secondary RF, which occurs secondary to such causes as drug therapy, malignant tumors, and chronic infections (e.g., tuberculosis, histoplasmosis, actinomycosis) (1,5). Idiopathic RF often shows manifestations of an autoimmune disease and it has been found to occasionally occur as an extrapancreatic lesion of autoimmune pancreatitis. More recently, some forms of idiopathic RF are considered to be a part of the spectrum of IgG4-related disease (5-9), which has newly been recognized to be a fibro-inflammatory condition characterized by several features: a tendency to form tumefactive lesions at multiple sites, a characteristic histopathological appearance, and often, but not always, an elevated serum IgG4 concentration (10). Umehara et al. reported the comprehensive diagnostic criteria for IgG4-related disease as follows: 1. clinical examination showing characteristic diffuse/localized swelling or masses in single or multiple organs; 2. An elevated serum IgG4 concentration (>135 mg/dL); and 3. A histopathological examination showing marked lymphocyte and plasmacytic infiltration and fibrosis, and the infiltration of IgG4+ plasma cells of >40% and >10 IgG4+ plasma cells/HPF (11). Based on these criteria, we confirmed the definitive diagnosis of IgG4-related disease in our patient. Koo et al. reported that among patients with IgG4-related RF, all had dense lymphoplasmacytic infiltrations, 88.9% of them showed storiform fibrosis, and 44.4% had obliterative phlebitis (6). At the time our patient received antibiotic therapy for acute infectious pleurisy, it was possible that this therapy had an effect on the etiology of RF. However, our patient was diagnosed as having idiopathic IgG4-related RF that showed the typical pathological features. There were no other findings of secondary RF due to drug therapy, malignant tumors, or chronic infections. The clinical course of our patient is considered to have important clinical implications: IgG4-related RF can spontaneously remit without any treatment. In fact, unexpectedly, a spontaneous remission of his clinical symptoms and radiological abnormalities associated with IgG4-related RF occurred during hospitalization. To the best of our knowledge, there is only one other reported case of a spontaneous remission of IgG4-related RF. Miura and Miyachi reported a patient who showed a spontaneous remission of IgG4-related RF, although it recurred 5 years after remission (12). However, they diagnosed the patient to have IgG4-related RF because the serum IgG4 levels strongly correlated with the disease behavior of RF; however, this case was not biopsy proven. Therefore, the present report describes what we believe to be the first case of a spontaneous regression of biopsy proven IgG4-related RF. The precise mechanism of the spontaneous remission in our patient is unclear. In IgG4-related disease, serum autoantibodies including anti-lactoferrin, rheumatoid factor, allergic disorder, and elevated levels of serum IgE are often detected, and therefore the pathogenesis of IgG4-related disease is generally assumed from autoimmune and allergic responses (13,14). In terms of autoimmune response, although no specific antigen targets for the IgG4 antibodies have been identified in patients with IgG4-related disease, IgG4 antibodies can activate both complements via the alternate pathway and leukocytes and can induce leukocyte-dependent tissue damage (15). With regard to allergic response, there is a known association between the preferential Th2-type response and an increase in the expression of the Th2 cytokines IL-4, IL-5, IL-10, and IL-13. Activated regulatory T cells secrete transforming growth factor-β, which is responsible for the fibrosis seen in IgG4-related disease (16). We surmise that one of the reasons for this is that all types of cytokines might be regulated for an immune and allergic self-limiting response. In fact, some cases of a spontaneous regression of IgG4-related pulmonary and hepatic inflammatory pseudotumor have been reported similar to our case (17,18). In clinical practice, the first goal of treatment in RF is the relief of ureteral obstruction to prevent any significant impairment in the function of one or both kidneys. Recently, a conservative approach followed by the administration of medical therapy (e.g., steroids) has become popular (19), and therefore, the long-term disease behavior of untreated IgG4-related RF remains unknown. However, our patient spontaneously showed complete remission during the clinical course. Importantly, IgG4-related RF rapidly responds to steroid treatment (3,8). Taking the long-term adverse effects of steroid therapy together with the rapid response to steroid treatment, careful observation to determine whether or not the renal function is worsening in preparation for initiating steroid treatment may be one important treatment strategy in asymptomatic IgG4-related RF patients without IgG4-related kidney disease. However, because the natural history may be unclear, care should be taken to check for any frequent relapse of IgG4-related disease over the long term (12,20). In conclusion, we herein described the first known case of a spontaneous remission of biopsy proven IgG4-related RF. Because RF is essentially a rare disease, and the concept of IgG4-related disease is unfamiliar to many clinicians, few studies have been published on IgG4-related RF. Although the pathogenesis and long-term disease behavior of IgG4-related RF remains unknown, it will be important to continue to accumulate data and evaluate many cases of IgG4-related RF and identify the optimal therapeutic strategies.

The authors state that they have no Conflict of Interest (COI).
  20 in total

Review 1.  The role of IgG4 in cutaneous pathology.

Authors:  A Fernandez-Flores
Journal:  Rom J Morphol Embryol       Date:  2012       Impact factor: 1.033

Review 2.  Retroperitoneal fibrosis: evolving concepts.

Authors:  Augusto Vaglio; Alessandra Palmisano; Domenico Corradi; Carlo Salvarani; Carlo Buzio
Journal:  Rheum Dis Clin North Am       Date:  2007-11       Impact factor: 2.670

3.  Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis.

Authors:  D Corradi; R Maestri; A Palmisano; S Bosio; P Greco; L Manenti; S Ferretti; R Cobelli; G Moroni; A P Dei Tos; C Buzio; A Vaglio
Journal:  Kidney Int       Date:  2007-07-11       Impact factor: 10.612

4.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Authors:  Y Masaki; L Dong; N Kurose; K Kitagawa; Y Morikawa; M Yamamoto; H Takahashi; Y Shinomura; K Imai; T Saeki; A Azumi; S Nakada; E Sugiyama; S Matsui; T Origuchi; S Nishiyama; I Nishimori; T Nojima; K Yamada; M Kawano; Y Zen; M Kaneko; K Miyazaki; K Tsubota; K Eguchi; K Tomoda; T Sawaki; T Kawanami; M Tanaka; T Fukushima; S Sugai; H Umehara
Journal:  Ann Rheum Dis       Date:  2008-08-13       Impact factor: 19.103

Review 5.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

6.  IgG4-related lung disease.

Authors:  Rishi Raj
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

Review 7.  IgG4-related disease.

Authors:  Vinay S Mahajan; Hamid Mattoo; Vikram Deshpande; Shiv S Pillai; John H Stone
Journal:  Annu Rev Pathol       Date:  2013-10-02       Impact factor: 23.472

Review 8.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

9.  Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone.

Authors:  Eric F H van Bommel; Claire Siemes; Liesbeth E Hak; Sacha J van der Veer; Tadek R Hendriksz
Journal:  Am J Kidney Dis       Date:  2007-05       Impact factor: 8.860

10.  Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4.

Authors:  Yoh Zen; Manabu Onodera; Dai Inoue; Azusa Kitao; Osamu Matsui; Takahiro Nohara; Mikio Namiki; Satomi Kasashima; Atsuhiro Kawashima; Yasushi Matsumoto; Kazuyoshi Katayanagi; Tetsuya Murata; Shin Ishizawa; Noriko Hosaka; Ken Kuriki; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

View more
  2 in total

1.  IgG4-Related Laryngeal Disease as a Possible Cause of Idiopathic Subglottic Stenosis: A Case Report.

Authors:  Ádám Bach; Andrea Ambrus; Béla Iványi; Zoltán Tóbiás; Gholam Hossein Alim Marvasti; László Rovó
Journal:  Iran J Otorhinolaryngol       Date:  2021-03

2.  Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis.

Authors:  Akira Hanazono; Yui Sanpei; Hinako Shimada; Keita Yasuda; Yoshiko Takahashi; Homare Funasaka; Ryuichiro Sagehashi; Yuko Hiroshima; Hiroshi Nanjo; Masashiro Sugawara
Journal:  eNeurologicalSci       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.